HR 19
Lower Costs, More Cures Act of 2021
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
The Lower Costs, More Cures Act of 2021 aims to lower prescription drug costs and increase access to care through various reforms. It focuses on Medicare and Medicaid, requiring greater price transparency from drug manufacturers and pharmacy benefit managers (PBMs), capping out-of-pocket costs for Medicare beneficiaries, and establishing a mechanism for Medicare to negotiate drug prices. The bill also includes provisions to address issues like drug rebates, pass-through pricing, and manufacturer agreements to limit patent disputes, while also allowing for more flexibility in Medicare Part D plans.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cathy McMorris Rodgers
Cosponsors
A. Drew, IV Ferguson
Adam Kinzinger
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.